The timely identification of traditional and non-traditional precursors and risk factors for chronic kidney disease (CKD) (a systemic and frequent disease defined as a decreased kidney function documented by reduced glomerular filtration rate, or markers of kidney damage, or both) is relevant in clinical practice, as CKD increases the risk of developing end-stage renal disease and other serious comorbidities. A possible relationship between non-alcoholic fatty liver disease (NAFLD) (which is the most common chronic disease in many developed and developing countries) and CKD has obtained recent scientific interest.
Risk of kidney dysfunction in NAFLD / Mantovani, Alessandro; Zusi, Chiara; Dalbeni, Andrea; Grani, Giorgio; Buzzetti, Elena. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1381-6128. - 25:(2020), pp. 4288-4304. [10.2174/1381612825666191026113119]
Risk of kidney dysfunction in NAFLD
Grani, Giorgio;
2020
Abstract
The timely identification of traditional and non-traditional precursors and risk factors for chronic kidney disease (CKD) (a systemic and frequent disease defined as a decreased kidney function documented by reduced glomerular filtration rate, or markers of kidney damage, or both) is relevant in clinical practice, as CKD increases the risk of developing end-stage renal disease and other serious comorbidities. A possible relationship between non-alcoholic fatty liver disease (NAFLD) (which is the most common chronic disease in many developed and developing countries) and CKD has obtained recent scientific interest.File | Dimensione | Formato | |
---|---|---|---|
Mantovani_Kidney-dysfunction_2019.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.1 MB
Formato
Adobe PDF
|
1.1 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.